Functional Dyspepsia. Norbert Welkovics Heine van der Walt

Similar documents
CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

June By: Reza Gholami

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

Non-Ulcer Dyspepsia: what is it? What can we do with these patients? Overview. Dyspepsia Definition. Functional Dyspepsia. Dyspepsia the Basics

SUPPLEMENTARY INFORMATION Associated with

Dyspepsia is a problem commonly seen by primary

Functional Heartburn and Dyspepsia

Management of dyspepsia and of Helicobacter pylori infection

Corporate Medical Policy

A Guide to Gastrointestinal Motility Disorders

Outline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments

The Role of Food in the Functional Gastrointestinal Disorders

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Treatment of Helicobacter pylori Infection

F A M N O P R S ! D !

Dyspepsia and upper gastrointestinal bleeding. Dr. Wayne H.C. Hu 胡興正

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

Last Revised: September 15 Last Reviewed: September EOSINOPHILIC ESOPHAGITIS (EOE)/PPI-RESPONSIVE ESOPHAGEAL EOSINOPHILIA (PPI-REE)

QUICK QUERIES. Topical Questions, Sound Answers

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

FUNCTIONAL DISORDERS ROME IV CRITERIA AND DIAGNOSTIC QUESTIONNAIRE DDW 2016,REVIEW. Presented by; Marjan Mokhtare Gastroenterologist, IUMS

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

Definition, Pathogenesis, and Management of That Cursed Dyspepsia

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus

Objectives. Identify age-related changes in the gastrointestinal tract

Functional Dyspepsia

Clinical Trial of Efcid (Himcocid) in Patients of Acid Peptic Disease

Reflux of gastric contents, particularly acid, into the esophagus

Functional Dyspepsia

What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?

Dyspepsia: alarm symptoms, investigation and management

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

Setting The setting was primary care. The economic study was conducted in Canada.

Clinical problems related to GI involvement in SSc

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint

Irritable Bowel Syndrome

Drossman Gastroenterology 55 Vilcom Center Drive Boyd Hall, Suite 110 Chapel Hill, NC 27514

One-third of adults experience pain or discomfort in

A Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD

Number of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI

The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

J Neurogastroenterol Motil, Vol. 17 No. 3 July, 2011 DOI: /jnm Journal of Neurogastroenterology and Motility

Clinical Policy Title: Breath Testing for H. Pylori

HELICOBACTER PYLORI; PATIENTS WITH FUNCTIONAL DYSPEPSIA

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

ABDOMINAL PAIN, CHRONIC

Peptic Ulcer Disease Update

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori

Module 2 Heartburn Glossary

Subgroups of Dyspepsia

Updates in Evaluation and Management of Dyspepsia and H. Pylori Infection

An approach to dyspepsia for the pharmacist

Disease of the Stomach

Clinical Profile and Esophagogastroduodenoscopy Finding in Patients with Acid Peptic Disease at a Tertiary Health Care Centre

Original Article. Rattanasupar A Attasaranya S Ovartlarnporn B ABSTRACT

GI update. Common conditions and concerns my patients frequently asked about

Management of Dyspepsia

Managing Upper GI Tract Disease. Michael Herzlinger, MD Pediatric Gastroenterology 7/2018

Copy right protected Page 1

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.

GASTROESOPHAGEAL REFLUX

Gut complications in autonomic dysfunction Qasim Aziz, PhD, FRCP

Peptic ulcer disease Disorders of the esophagus

Clinical Manifestations of Gastrointestinal Disorders. Awni Taleb Abu sneineh

Setting The setting was secondary care. The economic study was carried out in Hong Kong, China.

What s New & Common Presentations in Upper GI. Dr Philip Woodland Consultant Gastroenterologist Royal London Hospital

Clinical Evaluation of Himcocid Suspension in Patients with Non-ulcer Dyspepsia

Gastrointestinal symptoms are still common in a general Western population

11/19/2012. Comparison between PPIs G CELL. Risk ratio (95% CI) Patient subgroup. gastrin. S-form of omeprazole. Acid sensitive. coated.

190 Index Case studies, abdominal pain, 2 Crohn s disease, 2 3, cyclic vomiting syndrome (CVS), 2 fecal incontinence (FI), 2 medical c

The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

Objectives. Pain Types Brief Review. Referred Pain. Chronic/Recurrent Abdominal Pain 1/12/2017. I have no conflicts of interest to disclose

Functional dyspepsia: recent advances in pathophysiology. Citation Hong Kong Practitioner, 1998, v. 20 n. 6, p

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School

Digestion. Text. What You Don t Know Can Hurt You!

H. Pylori and Dyspepsia

The Importance of Hypochondriasis in Dyspeptic Patients

Epidemiology of Peptic Ulcer Disease

Catherine Kerschen DO, FACOI Michigan State University College of Osteopathic Medicine

ESOPHAGEAL MOTOR DISORDERS

Upper Gastrointestinal Manifestations in Chronic Renal Failure Through Upper Gastrointestinal Endoscopy

I. Kalfus MD, D. Riff MD, R. Fathi PhD, D. Graham MD

DIAGNOSTIC YIELD OF UPPER GI ENDOSCOPY AND ULTRASONOGRAPHY IN PATIENTS OF DYSPEPSIA

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

Policy Evaluation: Proton Pump Inhibitors (PPIs)

Dyspepsia and Chronic Gastritis

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Fecal incontinence causes 196 epidemiology 8 treatment 196

Clinical Policy Title: Noninvasive testing for H. pylori

1. Appropriateness of Gastroscopy: Dyspepsia 1

An Approach to Abdominal Pain

Transcription:

Norbert Welkovics Heine van der Walt

Characteristics: Central abdomen Pain or discomfort Not associated with bowel movements No structural or biochemical abnormalty Definition Part of Gastroduodenal disorders (Rome II)

Fx Gastro-intstinal disorders A. Esophagial disorders E. Billiary disorders Rome II (1999) A1. Globus E1. Gallbladder dysfunction A2. Rumination Syndrome E2. Sphincter of Odi dysfunction A3. Functional chest pain of presumed oesophageal origin A4. Functional heartburn A5. Functional dysphagia A6. Unspecified oesophageal disorder B. Gastroduodenal disorders F. Anorectal disorders B1. Functional dyspepsia F1. Functional faecal incontinence B1a. Ulcer like dyspepsia F2. Functional anorectal pain B1b. Dysmotility like dyspepsia F2a. Levator ani syndrome B1c. Non-specific dyspepsia F2b. Proctalgia fugax B2. Aerophagia B3. Functional vomiting C. Bowel disorders C1. Irritable bowel syndrome C2. Functional abdominal bloating C3. Functional constipation C4. Functional diarrhoea C5. Unspecified functional bowel disorder D. Functional abdominal pain D1. Functional abdominal pain syndrome D2. Unspecified functional abdominal pain

Organic dyspepsia Classification PUD, GERD, Pancreatico-billiry disease Functional dyspepsia Ulcer-like dyspepsiea Pain Dysmotility-like dyspepsia Discomort; nausea, vomiting, postprandial fullness and upper abdominal bloating Reflux-like dyspepsia Heartburn but not the predominant symptom

Epidemiology Common complaint (15 25%) On upper GIT endoscopy: Peptic ulcer disease 22% Esophagitis 10% Cancer 1% Functional dyspepsia 67% Comparable to asymptomatics

Aetiology Cause and effect difficult to establish 1. Symptoms experienced are intermittent and changing 2. High placebo response rate (30%) 3. No specific findings in all patients present 4. Findings present in asymptomatic patients as well 5. Symptoms and findings often do not correlate 6. There is no universal effective treatment 7. The response to treatment is difficult to predict

Aetiology Postulates Ulcer-like like Dyspepsia Dysmotility-like like Dyspepsia Helicobacter pylori Gastritis / Duodenitis Missed PUD Acid sensitivity Occult GERD Gastroparesis Abnormal relaxation Visceral hypersensitivity Brain-gut disorder Psychological disorder

Aetiology Helicobacter pylori Controversial: Background infection rates increase with age H.pylori gastritis equal in asymptomatics Possible CagA+ strain For treatment WHO declared HP carcinogen Response to treatment 20% at 1 year

Aetiology Helicobacter pylori Against treatment Response to PPI not to antibiotics Low background infection rate in 1 st world countries MAASTRICHT CONSENSUS Test and treat approach in uninvestigated dyspepsia in patients younger than 45 in the absence of: 1. Alarm symptoms 2. NSAID use 3. Predominant reflux symptoms 4. Family history of gastric carcinoma

Aetiology Gastritis NSAID gastropathy and functional dyspepsia can occur simultaniously Stop NSAID If symptoms don t improve, treat as functional dyspepsia

Aetiology Duodenitis Presence of past PUD diagnosis Manage as PUD even if endoscopy normal Missed PUD? Absence of past history Treat as functional dyspepsia

Aetiology Acid sensitivity Normal acid secretion Acid sensitivity increased 20% incidence in functional dyspepsia Decreased acid clearance by duodenum? H 2 treatment response 20% above placebo rate

Aetiology Occult GERD Reflux s a normal phenominon High positive predictive value If dominant symptom = GERD Might form part of functional dyspepsia